Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Acq. announced
Appointed COO
Quarterly results
Director departure
Appointed director
CC transcript
SYNAGEVA BIOPHARMA CORP (GEVA) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/12/2016 SC 13G/A SMALLCAP WORLD FUND INC reports a 0% stake in Synageva BioPharma Corp.
06/24/2015 SC 13D/A BAKER BROS. ADVISORS LP reports a 0% stake in Synageva BioPharma Corp.
06/23/2015 8-K Form 8-K - Current report
06/22/2015 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
06/22/2015 425 Form 425 - Prospectuses and communications, business combinations
06/22/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
06/12/2015 425 Form 425 - Prospectuses and communications, business combinations
06/12/2015 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
06/11/2015 425 Form 425 - Prospectuses and communications, business combinations
06/11/2015 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
06/10/2015 425 Form 425 - Prospectuses and communications, business combinations
06/10/2015 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
06/10/2015 425 Form 425 - Prospectuses and communications, business combinations
06/10/2015 SC 13G/A Capital Research Global Investors reports a 4.7% stake in Synageva BioPharma Corp.
06/10/2015 SC 13G/A FMR LLC reports a 2.2% stake in SYNAGEVA BIOPHARMA CORP
06/09/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
06/08/2015 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
06/05/2015 425 Form 425 - Prospectuses and communications, business combinations
06/05/2015 SC 13G/A COLUMBIA WANGER ASSET MANAGEMENT LLC reports a
06/01/2015 425 Form 425 - Prospectuses and communications, business combinations
06/01/2015 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
05/29/2015 425 Form 425 - Prospectuses and communications, business combinations
05/29/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
05/22/2015 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
05/22/2015 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
05/11/2015 425 Form 425 - Prospectuses and communications, business combinations
05/11/2015 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
05/11/2015 425 Form 425 - Prospectuses and communications, business combinations
05/08/2015 425 Form 425 - Prospectuses and communications, business combinations
05/07/2015 SC 13D/A BAKER BROS. ADVISORS LP reports a 32% stake in Synageva BioPharma Corp.
05/06/2015 8-K Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other E...
Docs: "Agreement and Plan of Reorganization, among Alexion Pharmaceuticals, Inc., Pulsar Merger Sub Inc., Galaxy Merger Sub LLC and Synageva BioPharma Corp. Schedules to the Agreement and Plan of Reorganization have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The registrant will furnish copies of any such schedules to the U.S. Securities and Exchange Commission upon request",
"Third Amended and Restated Bylaws of Synageva BioPharma Corp. (marked)",
"Alexion to Acquire Synageva to Strengthen Global Leadership in Developing and Commercializing Transformative Therapies for Patients with Devastating and Rare Diseases"
05/06/2015 425 Form 425 - Prospectuses and communications, business combinations
05/06/2015 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
05/06/2015 425 Form 425 - Prospectuses and communications, business combinations
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy